| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAGE THERAPEUTICS | 10,000 | 315,000 | 0.06% | ||
| 2 | CELLECTAR BIOSCIENCES INC | 530,000 | 318,000 | 0.07% | ||
| 3 | SCYNEXIS INC | 100,000 | 739,000 | 0.15% | ||
| 4 | Curis, Inc | 600,000 | 846,000 | 0.17% | ||
| 5 | BRISTOL MYERS SQUIBB CO | 5,000 | 985,000 | 0.20% | ||
| 6 | MINERVA NEUROSCIENCES INC COM | 175,000 | 1,059,000 | 0.22% | ||
| 7 | Agile Therapeutics, Inc. | 150,000 | 1,095,000 | 0.23% | ||
| 8 | APPLIED GENETIC TECHNOL CORP | 60,600 | 1,128,000 | 0.23% | ||
| 9 | ADVAXIS INC COM NEW | 350,000 | 1,176,000 | 0.24% | ||
| 10 | Cellectar Biosciences @4.68 8/ | 530,000 | 1,177,000 | 0.24% | ||
| 11 | REGULUS THERAPEUTICS INC | 200,000 | 1,366,000 | 0.28% | ||
| 12 | CELSUS THERAPEUTICS PLC | 244,500 | 1,491,000 | 0.31% | ||
| 13 | CERULEAN PHARMA INC | 450,000 | 1,899,000 | 0.39% | ||
| 14 | ALDER BIOPHARMACEUTICALS INC | 150,000 | 1,902,000 | 0.39% | ||
| 15 | ZS PHARMA INC | 50,000 | 1,962,000 | 0.40% | ||
| 16 | Aquinox Pharmaceuticals Inc | 300,000 | 1,998,000 | 0.41% | ||
| 17 | AGENUS INC | 650,000 | 2,022,000 | 0.42% | ||
| 18 | SOCIETAL CDMO INC | 700,000 | 2,072,000 | 0.43% | ||
| 19 | AVALANCHE BIOTECHNOLOGIES IN | 65,000 | 2,222,000 | 0.46% | ||
| 20 | GALECTIN THERAPEUTICS INC COM | 450,400 | 2,266,000 | 0.47% | ||
| 21 | AUSPEX PHARMACEUTICALS INC | 100,000 | 2,567,000 | 0.53% | ||
| 22 | GENVEC INC | 1,329,300 | 2,765,000 | 0.57% | ||
| 23 | KITE PHARMA INCORPORATED | 100,000 | 2,850,000 | 0.59% | ||
| 24 | CLOVIS ONCOLOGY INC | 70,000 | 3,175,000 | 0.65% | ||
| 25 | KINDRED BIOSCIENCES INC | 350,000 | 3,238,000 | 0.67% | ||
| 26 | GLYCOMIMETICS INC | 472,300 | 3,278,000 | 0.67% | ||
| 27 | NANOSTRING TECHNOLOGIES INC | 300,000 | 3,282,000 | 0.68% | ||
| 28 | IMMUNE DESIGN CORP COM | 200,000 | 3,532,000 | 0.73% | ||
| 29 | ARRAY BIOPHARMA INC COM | 1,000,000 | 3,570,000 | 0.73% | ||
| 30 | ROCKWELL MED INC COM | 400,000 | 3,656,000 | 0.75% | ||
| 31 | VERSARTIS INC COM | 200,000 | 3,798,000 | 0.78% | ||
| 32 | ALNYLAM PHARMACEUTICALS INC | 50,000 | 3,905,000 | 0.80% | ||
| 33 | ALKERMES PLC SHS | 100,000 | 4,287,000 | 0.88% | ||
| 34 | SORRENTO THERAPEUTICS INC COM NEW | 1,000,000 | 4,520,000 | 0.93% | ||
| 35 | QUOTIENT LTD | 500,000 | 4,715,000 | 0.97% | ||
| 36 | PORTOLA PHARMACEUTICALS INC | 200,000 | 5,056,000 | 1.04% | ||
| 37 | EAGLE PHARMACEUTICALS INC COM | 400,000 | 5,060,000 | 1.04% | ||
| 38 | CHINA BIOLOGIC PRODS INC | 95,000 | 5,126,000 | 1.05% | ||
| 39 | SANGAMO BIOSCIENCES INCORPORATED | 500,000 | 5,393,000 | 1.11% | ||
| 40 | NEKTAR THERAPEUTICS COM | 450,000 | 5,432,000 | 1.12% | ||
| 41 | ACELRX PHARMACEUTICALS INC | 1,000,000 | 5,490,000 | 1.13% | ||
| 42 | PTC THERAPEUTICS INC | 125,000 | 5,501,000 | 1.13% | ||
| 43 | ARDELYX INC COM | 388,700 | 5,523,000 | 1.14% | ||
| 44 | HERON THERAPEUTICS INC | 700,000 | 5,831,000 | 1.20% | ||
| 45 | AGIOS PHARMACEUTICALS INC | 100,000 | 6,135,000 | 1.26% | ||
| 46 | NOVAVAX INC COM | 1,500,000 | 6,255,000 | 1.29% | ||
| 47 | ULTRAGENYX PHARMACEUTICAL INC COM | 120,000 | 6,792,000 | 1.40% | ||
| 48 | SYNAGEVA BIOPHARMA CORP | 100,000 | 6,878,000 | 1.41% | ||
| 49 | CHIMERIX INC | 250,000 | 6,905,000 | 1.42% | ||
| 50 | OMEROS CORP | 547,900 | 6,969,000 | 1.43% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-14-041889, filed 2014.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
